stella
beta
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT — Stella
Home
/
Hematopoietic Malignancy
/
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
View on ClinicalTrials.gov
Recruiting
Back to Hematopoietic Malignancy trials
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
The First Affiliated Hospital of Soochow university, Suzhou, Jiangsu